ABSTRACT
Objectives Few studies have explored whether the involvement of patients in shared decision-making (SDM) is beneficial to the management of systemic lupus erythematosus (SLE). Therefore, this study investigated the relationship between patient participation in SDM and their trust in physicians using data from the TRUMP2-SLE study.
Methods Data regarding the nine-item Shared Decision-Making Questionnaire (SDM-Q-9 scores), Trust in Physician Scale (TIPS) scores, and Abbreviated Wake Forest Physician Trust Scale (A-WFPTS) scores for interpersonal trust in a physician and trust in the medical profession were collected from patients with SLE who visited the outpatient clinics of five facilities in Japan through a self-administered questionnaire. The relationships between these scores were analyzed.
Results This study included 433 patients with SLE. The median baseline TIPS and A-WFPTS (attending physician version) scores were 82 (73–93) and 80 (70–95), respectively. A higher baseline SDM-Q-9 score was correlated with an increase in the TIPS score at 1 year (adjusted mean difference per 10-pt increase, 0.95 pt [95%CI 0.18–1.71]). A higher baseline SDM-Q-9 score was also correlated with a higher A-WFPTS score for interpersonal trust (adjusted mean difference per 10-pt increase, 2.16 pt [1.41-2.92]). The baseline A-WFPTS (general physician version) score of 65 (50–80) was also correlated with an increase in the A-WFPTS score at 1 year (adjusted mean difference per 10-pt increase, 1.28 pt [0.43–2.14]).
Conclusions Engagement of patients with SLE in SDM elevates their trust in the attending physicians and healthcare providers, potentially enhancing doctor-patient relationships and overall healthcare trust.
What is already known about this subject?
➢ The importance of the involvement of patients in shared decision-making (SDM) in the management of systemic lupus erythematosus (SLE) has been emphasized as one of the principles in the EULAR recommendation.
What does this study add?
➢ The baseline SDM-Q-9 scores were correlated with the Trust in Physician Scale (TIPS) and the attending physician version of the Abbreviated Wake Forest Physician Trust Scale (A-WFPTS) scores at 1 year.
➢ The baseline SDM-Q-9 scores at baseline were correlated with the general physician version of the A-WFPTS score at 1 year.
➢ These results indicate that the involvement of patients with SLE in SDM increases their trust in the attending physicians and physicians in general.
How might this impact on clinical practice or future developments?
➢ This study demonstrated the importance of SDM in maintaining long-term physician-patient relationship during the management of SLE.
➢ Involvement of patients with SLE in SDM may improve the doctor-patient relationship and trust in healthcare.
Competing Interest Statement
RY received speaker fees from GlaxoSmithKline PLC, AstraZeneca PLC, and Sanofi S.A..
Funding Statement
This work was supported by JSPS KAKENHI Grant Numbers JP19KT0021 (N. K.) and JP22K08567 (R. Y.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Institutional Review Board of Yokohama City University (F220600012).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵14 Noriaki Kurita and Hideaki Nakajima share last authorship.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
